These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26205450)

  • 1. Fate of Bioresorbable Vascular Scaffold Metallic Radio-Opaque Markers at the Site of Implantation After Bioresorption.
    Suwannasom P; Onuma Y; Campos CM; Nakatani S; Ishibashi Y; Tateishi H; Grundeken MJ; Stanetic B; Nieman K; Jonker H; Garcia-Garcia HM; Serruys PW;
    JACC Cardiovasc Interv; 2015 Jul; 8(8):1130-1132. PubMed ID: 26205450
    [No Abstract]   [Full Text] [Related]  

  • 2. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.
    Onuma Y; Dudek D; Thuesen L; Webster M; Nieman K; Garcia-Garcia HM; Ormiston JA; Serruys PW
    JACC Cardiovasc Interv; 2013 Oct; 6(10):999-1009. PubMed ID: 24156961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early neoatherosclerosis after bioresorbable vascular scaffold implantation: insights from optical coherence tomography.
    Sato T; Richardt G; Abdel-Wahab M
    Coron Artery Dis; 2016 Nov; 27(7):616-7. PubMed ID: 27228185
    [No Abstract]   [Full Text] [Related]  

  • 4. Accuracy of coronary computed tomography angiography for bioresorbable scaffold luminal investigation: a comparison with optical coherence tomography.
    Collet C; Sotomi Y; Cavalcante R; Asano T; Miyazaki Y; Tenekecioglu E; Kistlaar P; Zeng Y; Suwanasson P; de Winter RJ; Nieman K; Serruys PW; Onuma Y
    Int J Cardiovasc Imaging; 2017 Mar; 33(3):431-439. PubMed ID: 27896495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent Bioresorbable Vascular Scaffold by Optical Coherence Tomography Imaging at 5 Years.
    Moriyama N; Shishido K; Tobita K; Takada T; Ochiai T; Tsukuda S; Yamanaka F; Sugitatsu K; Mizuno S; Tanaka Y; Murakami M; Matsumi J; Takahashi S; Akasaka T; Saito S
    JACC Cardiovasc Interv; 2017 Jan; 10(2):e11-e13. PubMed ID: 28040440
    [No Abstract]   [Full Text] [Related]  

  • 6. Very Late Restenosis Following Bioresorbable Scaffold Implantation.
    Okuno T; Yahagi K; Horiuchi Y; Aoki J; Simonton CA; Rapoza R; Saito S; Kimura T; Tanabe K
    JACC Cardiovasc Interv; 2017 Sep; 10(18):e167-e169. PubMed ID: 28866033
    [No Abstract]   [Full Text] [Related]  

  • 7. Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data.
    Bourantas CV; Serruys PW; Nakatani S; Zhang YJ; Farooq V; Diletti R; Ligthart J; Sheehy A; van Geuns RJ; McClean D; Chevalier B; Windecker S; Koolen J; Ormiston J; Whitbourn R; Rapoza R; Veldhof S; Onuma Y; Garcia-Garcia HM
    EuroIntervention; 2015 Nov; 11(7):746-56. PubMed ID: 25308301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel 3-Dimensional Vessel and Scaffold Reconstruction Methodology for the Assessment of Strut-Level Wall Shear Stress After Deployment of Bioresorbable Vascular Scaffolds From the ABSORB III Imaging Substudy.
    Gogas BD; Yang B; Piccinelli M; Giddens DP; King SB; Kereiakes DJ; Ellis SG; Stone GW; Veneziani A; Samady H
    JACC Cardiovasc Interv; 2016 Mar; 9(5):501-3. PubMed ID: 26965940
    [No Abstract]   [Full Text] [Related]  

  • 9. Neoatherosclerosis as the Cause of Late Failure of a Bioresorbable Vascular Scaffold at 8 Months.
    Kang SH; Kang SJ; Kim WJ
    JACC Cardiovasc Interv; 2017 Sep; 10(18):1896-1898. PubMed ID: 28866035
    [No Abstract]   [Full Text] [Related]  

  • 10. In-scaffold restenosis in a previous left main bifurcation lesion treated with bioresorbable scaffold v-stenting.
    Miyazaki T; Panoulas VF; Sato K; Kawamoto H; Naganuma T; Latib A; Colombo A
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):e7-e10. PubMed ID: 25499306
    [No Abstract]   [Full Text] [Related]  

  • 11. Very late metallic stent malapposition and in-stent restenosis treated with a bioresorbable scaffold: a novel alternative for an old problem.
    Foin N; Lee R; Wong P; Low AF
    EuroIntervention; 2015 Aug; 11(4):e1. PubMed ID: 26298237
    [No Abstract]   [Full Text] [Related]  

  • 12. Development and receding of a coronary artery aneurysm after implantation of a fully bioresorbable scaffold.
    Nakatani S; Ishibashi Y; Suwannasom P; Grundeken MJ; Høj Christiansen E; Onuma Y; Serruys PW;
    Circulation; 2015 Feb; 131(8):764-7. PubMed ID: 25712060
    [No Abstract]   [Full Text] [Related]  

  • 13. Bioresorbable Scaffolds for the Management of Coronary Bifurcation Lesions.
    Kawamoto H; Ruparelia N; Tanaka A; Chieffo A; Latib A; Colombo A
    JACC Cardiovasc Interv; 2016 May; 9(10):989-1000. PubMed ID: 27198679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.
    Verheye S; Ormiston JA; Stewart J; Webster M; Sanidas E; Costa R; Costa JR; Chamie D; Abizaid AS; Pinto I; Morrison L; Toyloy S; Bhat V; Yan J; Abizaid A
    JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast leak mimicking detector malfunction in coronary artery calcium scoring.
    Makaryus JN; Saba SG; Makaryus AN
    J Cardiovasc Comput Tomogr; 2015; 9(6):597-8. PubMed ID: 26198264
    [No Abstract]   [Full Text] [Related]  

  • 16. Fate of side-branch jailing and a malapposed platinum marker after resorption of an everolimus-eluting bioresorbable vascular scaffold: serial optical coherence tomography observations.
    Karanasos A; Garcia-Garcia HM; van Geuns RJ; Regar E
    JACC Cardiovasc Interv; 2015 Mar; 8(3):e53-e54. PubMed ID: 25790767
    [No Abstract]   [Full Text] [Related]  

  • 17. Very Late Restenosis After Bioresorbable Scaffold Implantation Due to Simultaneous External Compression of the Scaffold and Intrascaffold Tissue Growth.
    Tanaka A; Ruparelia N; Kawamoto H; Latib A; Colombo A
    JACC Cardiovasc Interv; 2016 Jan; 9(2):e15-7. PubMed ID: 26723762
    [No Abstract]   [Full Text] [Related]  

  • 18. An Unusual Complication After Bioresorbable Scaffold Implantation: Visualization of Intramural Hematoma by Optical Coherence Tomography.
    Zhang BC; Karanasos A; Royaards KJ; Ligthart J; Regar E
    JACC Cardiovasc Interv; 2015 Aug; 8(9):e143-e145. PubMed ID: 26292606
    [No Abstract]   [Full Text] [Related]  

  • 19. Relation Between Bioresorbable Scaffold Sizing Using QCA-Dmax and Clinical Outcomes at 1 Year in 1,232 Patients From 3 Study Cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II).
    Ishibashi Y; Nakatani S; Sotomi Y; Suwannasom P; Grundeken MJ; Garcia-Garcia HM; Bartorelli AL; Whitbourn R; Chevalier B; Abizaid A; Ormiston JA; Rapoza RJ; Veldhof S; Onuma Y; Serruys PW
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1715-26. PubMed ID: 26585622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and Potential Mechanism(s) of Post-Procedural Rise of Cardiac Biomarker in Patients With Coronary Artery Narrowing After Implantation of an Everolimus-Eluting Bioresorbable Vascular Scaffold or Everolimus-Eluting Metallic Stent.
    Ishibashi Y; Muramatsu T; Nakatani S; Sotomi Y; Suwannasom P; Grundeken MJ; Cho YK; Garcia-Garcia HM; van Boven AJ; Piek JJ; Sabaté M; Helqvist S; Baumbach A; McClean D; de Sousa Almeida M; Wasungu L; Miquel-Hebert K; Dudek D; Chevalier B; Onuma Y; Serruys PW
    JACC Cardiovasc Interv; 2015 Jul; 8(8):1053-1063. PubMed ID: 26205444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.